The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Mannose-targeted systems for the delivery of therapeutics
Abstract
BACKGROUND: The specific targeting of nanomedicines to mannose receptors, highly expressed in cells of the immune system, performs a useful strategy for improving the efficacy of vaccines and chemotherapy. OBJECTIVE: This review discusses the potential of mannose-targeted drug/antigen delivery systems for vaccination and treatment of diseases localized in macrophages and other antigen-presenting cells. METHODS: The first part of the review describes the characteristics, localization and functions of mannose receptors. The following sections are devoted to the description of different methods used to deliver therapeutic agents, including mannose conjugates and mannosylated carriers or particulates (i.e., liposomes, nanoparticles and niosomes). RESULTS/CONCLUSIONS: A general overview of published reports confirms the effectiveness of mannosylation strategies, although the optimization and full exploitation of mannose-targeted drug delivery systems would require a deeper understanding of the structure-activity relationship. In the near future, these nanomedicines have the potential to treat a number of diseases (including cancer) and improve the quality of life of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862 · cited 1×
“In this context, liposomes containing Man-C4-Chol and a plasmid coding for Gp100, which is abundantly expressed in both murine and human melanoma [143] , covalently bound to ubiquitin (pUb-M gene) to enhance its degradation by proteasome and regulate the intracellular protein processing to be presented by MHC class I…”
BackgroundDC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
Geijtenbeek, T. B. H., Kwon, D. S., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Middel, J., Cornelissen, I. L. M. H. A., Nottet, H. S. L. M., KewalRamani, V. N., Littman, D. R., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)80694-7 · Cited by 2,447
Flynn, J. L., & Chan, J. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 2,155
Geijtenbeek, T. B. H., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Adema, G. J., van Kooyk, Y., & Figdor, C. G. (2000) · Cell · doi:10.1016/s0092-8674(00)80693-5 · Cited by 1,700
Saito, G., Swanson, J. A., & Lee, K.-D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00179-5 · Cited by 1,407
McKinney, J. D., zu Bentrup, K. H., Muñoz-Elías, E. J., Miczak, A., Chen, B., Chan, W.-T., Swenson, D., Sacchettini, J. C., Jacobs, W. R., & Russell, D. G. (2000) · Nature · doi:10.1038/35021074 · Cited by 1,360
Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Gordon, S. (2002) · Cell · doi:10.1016/s0092-8674(02)01201-1 · Cited by 1,155
Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J. P., & Katinger, H. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1100-1108.1996 · Cited by 1,114
Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function
Geijtenbeek, T. B. H., van Vliet, S. J., Koppel, E. A., Sanchez-Hernandez, M., Vandenbroucke-Grauls, C. M. J. E., Appelmelk, B., & van Kooyk, Y. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021229 · Cited by 1,061
C-type lectin receptors on dendritic cells and langerhans cells
Figdor, C. G., van Kooyk, Y., & Adema, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri723 · Cited by 842 · cited 1×
“, macrophages and dendritic cells (DCs)] [1-4] .”
BackgroundAntibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells
Tailleux, L., Schwartz, O., Herrmann, J.-L., Pivert, E., Jackson, M., Amara, A., Legres, L., Dreher, D., Nicod, L. P., Gluckman, J. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021468 · Cited by 643
Engering, A., Geijtenbeek, T. B. H., van Vliet, S. J., Wijers, M., van Liempt, E., Demaurex, N., Lanzavecchia, A., Fransen, J., Figdor, C. G., Piguet, V., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2118 · Cited by 630
Drickamer, K. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00009-3 · Cited by 623
East, L. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00319-7 · Cited by 621
Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D., & Moore, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7293-7305.2002 · Cited by 553
Mahnke, K., Guo, M., Lee, S., Sepulveda, H., Swain, S. L., Nussenzweig, M., & Steinman, R. M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.3.673 · Cited by 544
Self- and nonself-recognition by C-type lectins on dendritic cells
Geijtenbeek, T. B. H., van Vliet, S. J., Engering, A., 't Hart, B. A., & van Kooyk, Y. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104558 · Cited by 503
DC-SIGN–ICAM-2 interaction mediates dendritic cell trafficking
Geijtenbeek, T. B. H., Krooshoop, D. J. E. B., Bleijs, D. A., van Vliet, S. J., van Duijnhoven, G. C. F., Grabovsky, V., Alon, R., Figdor, C. G., & van Kooyk, Y. (2000) · Nature Immunology · doi:10.1038/79815 · Cited by 499
Mannose Receptor-Mediated Regulation of Serum Glycoprotein Homeostasis
Lee, S. J., Evers, S., Roeder, D., Parlow, A. F., Risteli, J., Risteli, L., Lee, Y. C., Feizi, T., Langen, H., & Nussenzweig, M. C. (2002) · Science · doi:10.1126/science.1069540 · Cited by 484
Affinity enhancement by multivalent lectin–carbohydrate interaction
Lee, R. T., & Lee, Y. C. (2000) · Glycoconjugate Journal · doi:10.1023/a:1011070425430 · Cited by 469
Soilleux, E. J., Morris, L. S., Leslie, G., Chehimi, J., Luo, Q., Levroney, E., Trowsdale, J., Montaner, L. J., Doms, R. W., Weissman, D., et al. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.3.445 · Cited by 458
How C-type lectins detect pathogens: C-type lectins and pathogens
Cambi, A., Koopman, M., & Figdor, C. G. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00506.x · Cited by 448
Engering, A. J., Cella, M., Fluitsma, D., Brockhaus, M., Hoefsmit, E. C. M., Lanzavecchia, A., & Pieters, J. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270941 · Cited by 400
The mannose receptor: linking homeostasis and immunity through sugar recognition
TAYLOR, P., GORDON, S., & MARTINEZPOMARES, L. (2005) · Trends in Immunology · doi:10.1016/j.it.2004.12.001 · Cited by 368
Mannose‐binding lectin in innate immunity: past, present and future
Dommett, R. M., Klein, N., & Turner, M. W. (2006) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00649.x · Cited by 342
Taylor, M. E., Bezouska, K., & Drickamer, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46005-x · Cited by 327
Tan, M. C. A. A., Mommaas, A. M., Drijfhout, J. W., Jordens, R., Onderwater, J. J. M., Verwoerd, D., Mulder, A. A., van der Heiden, A. N., Scheidegger, D., Oomen, L. C. J. M., et al. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270942 · Cited by 325
Control of HIV despite the Discontinuation of Antiretroviral Therapy
Lisziewicz, J., Rosenberg, E. S., Lieberman, J., Jessen, H. K., Lopalco, L., Siliciano, R. F., Walker, B. D., & Lori, F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905273402114 · Cited by 324
Ligand recognition by antigen-presenting cell C-type lectin receptors
McGreal, E. P., Miller, J. L., & Gordon, S. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.12.001 · Cited by 310
Casadevall, A., Cleare, W., Feldmesser, M., Glatman-Freedman, A., Goldman, D. L., Kozel, T. R., Lendvai, N., Mukherjee, J., Pirofski, L.-A., Rivera, J., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1437 · Cited by 298
Neoglycoconjugates : preparation and applications
Lee, Y. C., & Lee, R. T. (1994) · Cited by 290
Maeda, N., Nigou, J., Herrmann, J.-L., Jackson, M., Amara, A., Lagrange, P. H., Puzo, G., Gicquel, B., & Neyrolles, O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200586200 · Cited by 269
Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis
Steinman, L., & Zamvil, S. S. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.08.014 · Cited by 265
Karanikas, V, Hwang, L. A., Pearson, J., Ong, C. S., Apostolopoulos, V, Vaughan, H., Xing, P. X., Jamieson, G., Pietersz, G., Tait, B., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119825 · Cited by 263
Development of vaccines against meningococcal disease
Jódar, L., Feavers, I. M., Salisbury, D., & Granoff, D. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08416-7 · Cited by 250
Rosenqvist, E., Høiby, E. A., Wedege, E., Bryn, K., Kolberg, J., Klem, A., Rønnild, E., Bjune, G., & Nøkleby, H. (1995) · Infection and Immunity · doi:10.1128/iai.63.12.4642-4652.1995 · Cited by 249
Caparrós, E., Munoz, P., Sierra-Filardi, E., Serrano-Gómez, D., Puig-Kröger, A., Rodríguez-Fernández, J. L., Mellado, M., Sancho, J., Zubiaur, M., & Corbí, A. L. (2006) · Blood · doi:10.1182/blood-2005-03-1252 · Cited by 238
Harb, O. S., Gao, L., & Kwaik, Y. A. (2000) · Environmental Microbiology · doi:10.1046/j.1462-2920.2000.00112.x · Cited by 224
Advances in combating fungal diseases: vaccines on the threshold
Cutler, J. E., Deepe Jr, G. S., & Klein, B. S. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1537 · Cited by 222
The critical role of Th1-dominant immunity in tumor immunology
Nishimura, T., Nakui, M., Sato, M., Iwakabe, K., Kitamura, H., Sekimoto, M., Ohta, A., Koda, T., & Nishimura, S. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/pl00014051 · Cited by 211
Casadevall, A., Mukherjee, J., Devi, S. J. N., Schneerson, R., Robbins, J. B., & Scharff, M. D. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/165.6.1086 · Cited by 210
Bennett, K., Levine, T., Ellis, J. S., Peanasky, R. J., Michael Samloff, I., Kay, J., & Chain, B. M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220626 · Cited by 203
Divergent roles for C-type lectins expressed by cells of the innate immune system
MCGREAL, E., MARTINEZPOMARES, L., & GORDON, S. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.06.013 · Cited by 196
Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial
(1994) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068903 · Cited by 195
Hodges, A., Sharrocks, K., Edelmann, M., Baban, D., Moris, A., Schwartz, O., Drakesmith, H., Davies, K., Kessler, B., McMichael, A., et al. (2007) · Nature Immunology · doi:10.1038/ni1470 · Cited by 192
Wessels, M. R., Paoletti, L. C., Kasper, D. L., DiFabio, J. L., Michon, F., Holme, K., & Jennings, H. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114858 · Cited by 191
Chono, S., Tanino, T., Seki, T., & Morimoto, K. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.1.0010 · Cited by 190
Feinberg, H., Castelli, R., Drickamer, K., Seeberger, P. H., & Weis, W. I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609689200 · Cited by 185
Liposomal delivery of antigen to human dendritic cells
Copland, M. J., Baird, M. A., Rades, T., McKenzie, J. L., Becker, B., Reck, F., Tyler, P. C., & Davies, N. M. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00536-4 · Cited by 184
Endosomal aspartic proteinases are required for invariant-chain processing.
Marić, M., Taylor, M. D., & Blum, J. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2171 · Cited by 182
Specific Degradation of Polysaccharides
Lindberg, B., Lōnngren, J., & Svensson, S. (1975) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/s0065-2318(08)60297-8 · Cited by 176
Apostolopoulos, V., Pietersz, G. A., Tsibanis, A., Tsikkinis, A., Drakaki, H., Loveland, B. E., Piddlesden, S. J., Plebanski, M., Pouniotis, D. S., Alexis, M. N., et al. (2006) · Breast Cancer Research · doi:10.1186/bcr1505 · Cited by 173
Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma
Loveland, B. E., Zhao, A., White, S., Gan, H., Hamilton, K., Xing, P.-X., Pietersz, G. A., Apostolopoulos, V., Vaughan, H., Karanikas, V., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1574 · Cited by 172
Leteux, C., Chai, W., Loveless, R. W., Yuen, C.-T., Uhlin-Hansen, L., Combarnous, Y., Jankovic, M., Maric, S. C., Misulovin, Z., Nussenzweig, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1117 · Cited by 168
Antigenic Targeting of the Human Mannose Receptor Induces Tumor Immunity
He, L.-Z., Crocker, A., Lee, J., Mendoza-Ramírez, J.-L., Wang, X.-T., Vitale, L. A., O’Neill, T. J., Petromilli, C., Zhang, H., Lopez, J., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6259 · Cited by 167
Carbohydrate‐independent recognition of collagens by the macrophage mannose receptor
Martínez‐Pomares, L., Wienke, D., Stillion, R. J., McKenzie, E. J., Arnold, J. N., Harris, J., McGreal, E. P., Sim, R. B., Isacke, C. M., & Gordon, S. (2006) · European Journal of Immunology · doi:10.1002/eji.200535685 · Cited by 165
Chono, S., Tanino, T., Seki, T., & Morimoto, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.011 · Cited by 164 · cited 2×
“More recently, Chono and co-workers [124] confirmed that the efficient antibacterial effects of mannosylated CPFX liposomes against intracellular parasites in alveolar APCs may be exhibited at a lower dose than that used in clinical situations.”
BackgroundKim, T. H., Jin, H., Kim, H. W., Cho, M.-H., & Cho, C. S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0540 · Cited by 164
Mannose receptor-targeted vaccines
Keler, T., Ramakrishna, V., & Fanger, M. W. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.12.1953 · Cited by 163
The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases
Miller, S. D., & Karpus, W. J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90173-2 · Cited by 163
Group B streptococcal infections
Edwards, M. S. (1990) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199010000-00040 · Cited by 158
Wijagkanalan, W., Kawakami, S., Takenaga, M., Igarashi, R., Yamashita, F., & Hashida, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.011 · Cited by 158
Chono, S., Tanino, T., Seki, T., & Morimoto, K. (2006) · Journal of drug targeting · doi:10.1080/10611860600834375 · Cited by 157
Mannosylated niosomes as adjuvant–carrier system for oral genetic immunization against Hepatitis B
Jain, S., Singh, P., Mishra, V., & Vyas, S. P. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.04.002 · Cited by 153
Placental expression of DC‐SIGN may mediate intrauterine vertical transmission of HIV
Soilleux, E. J., Morris, L. S., Lee, B., Pöhlmann, S., Trowsdale, J., Doms, R. W., & Coleman, N. (2001) · The Journal of Pathology · doi:10.1002/path.1026 · Cited by 146
Han, Y., Ulrich, M. A., & Cutler, J. E. (1999) · The Journal of Infectious Diseases · doi:10.1086/314779 · Cited by 145
Devi, S. J. (1996) · Vaccine · doi:10.1016/0264-410x(95)00256-z · Cited by 145
Anderson, P. W., Pichichero, M. E., Insel, R. A., Betts, R. F., Eby, R., & Smith, D. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.4.1181 · Cited by 141
Ni, J., Song, H., Wang, Y., Stamatos, N. M., & Wang, L. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0502816 · Cited by 138
Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host
Pirofski, L., & Casadevall, A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.1.1 · Cited by 138
d -Mannose-Modified Iron Oxide Nanoparticles for Stem Cell Labeling
Horák, D., Babič, M., Jendelová, P., Herynek, V., Trchová, M., Pientka, Z., Pollert, E., Hájek, M., & Syková, E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc060186c · Cited by 135
Role of macrophages during Theiler's virus infection
Rossi, C. P., Delcroix, M., Huitinga, I., McAllister, A., van Rooijen, N., Claassen, E., & Brahic, M. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3336-3340.1997 · Cited by 128
Lee, H., Scanlan, C. N., Huang, C., Chang, A. Y., Calarese, D. A., Dwek, R. A., Rudd, P. M., Burton, D. R., Wilson, I. A., & Wong, C. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353105 · Cited by 125
Wang, L., Ni, J., Singh, S., & Li, H. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.12.020 · Cited by 125
Mannose Receptor Expression and Function Define a New Population of Murine Dendritic Cells
McKenzie, E. J., Taylor, P. R., Stillion, R. J., Lucas, A., Harris, J., Gordon, S., & Martínez‐Pomares, L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4975 · Cited by 123
Baumann, R., Casaulta, C., Simon, D., Conus, S., Yousefi, S., & Simon, H. (2003) · The FASEB Journal · doi:10.1096/fj.03-0110com · Cited by 123
Oligolysine-based Oligosaccharide Clusters
Frison, N., Taylor, M. E., Soilleux, E. J., Bousser, M.-T., Mayer, R., Monsigny, M. L. P., Drickamer, K., & Roche, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302483200 · Cited by 122
Kim, T. H., Nah, J. W., Cho, M., Park, T. G., & Cho, C. S. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.434 · Cited by 117
Collectins: sentinels of innate immunity
Gupta, G., & Surolia, A. (2007) · BioEssays · doi:10.1002/bies.20573 · Cited by 116
Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses
Apostolopoulos, V., Barnes, N. C., Pietersz, G. A., & McKenzie, I. F. C. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00090-6 · Cited by 116
Ramakrishna, V., Treml, J., Vitale, L. A., Connolly, J. E., O’Neill, T. J., Smith, P. A., Jones, C. L., He, L.-Z., Goldstein, J., Wallace, P. K., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2845 · Cited by 114
Hattori, Y., Kawakami, S., Suzuki, S., Yamashita, F., & Hashida, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.141 · Cited by 111
Hattori, Y., Suzuki, S., Kawakami, S., Yamashita, F., & Hashida, M. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.08.012 · Cited by 110
Synthesis, Characterization, and Bioavailability of Mannosylated Shell Cross-Linked Nanoparticles
Joralemon, M. J., Murthy, K. S., Remsen, E. E., Becker, M. L., & Wooley, K. L. (2004) · Biomacromolecules · doi:10.1021/bm0344710 · Cited by 109
TODA, S., Ishii, N., Okada, E., Kusakabe, K., Arai, H., Hamajima, K., Gorai, I., Nishioka, K., & Okuda, K. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00307.x · Cited by 106
Lipid Carrier Systems for Targeted Drug and Gene Delivery
Hashida, M., Kawakami, S., & Yamashita, F. (2005) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.53.871 · Cited by 97
Mayer, A., Francis, R. J., Sharma, S. K., Tolner, B., Springer, C. J., Martin, J., Boxer, G., Bell, J., Green, A. J., Hartley, J. A., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0769 · Cited by 95
Koppel, E. A., Ludwig, I. S., Hernandez, M. S., Lowary, T. L., Gadikota, R. R., Tuzikov, A. B., Vandenbroucke‐Grauls, C. M. J. E., van Kooyk, Y., Appelmelk, B. J., & Geijtenbeek, T. B. H. (2004) · Immunobiology · doi:10.1016/j.imbio.2004.03.003 · Cited by 94
Mannan Mucin-1 Peptide Immunization: Influence of Cyclophosphamide and the Route of Injection
Karanikas, V., Thynne, G., Mitchell, P., Ong, C.-S., Gunawardana, D. H., Blum, R., Pearson, J. M., Lodding, J., Pietersz, G. A., Broadbent, R., et al. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200103000-00012 · Cited by 93
Orientation of Bound Ligands in Mannose-binding Proteins
Ng, K. K.-S., Kolatkar, A. R., Park-Snyder, S., Feinberg, H., Clark, D. A., Drickamer, K., & Weis, W. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200493200 · Cited by 93
DermaVir: A Novel Topical Vaccine for HIV/AIDS
Lisziewicz, J., Trocio, J. N., Whitman, L., Varga, G., Xu, J., Bakare, N., Erbacher, P., Fox, C. H., Woodward, R. A., Markham, P., et al. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23535.x · Cited by 92
Lu, Y. Q., Kawakami, S., Yamashita, F., & Hashida, M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.03.028 · Cited by 90
The Expression and Function of Cathepsin E in Dendritic Cells
Chain, B., Free, P., Medd, P. G., Swetman, C., Tabor, A. B., & Terrazzini, N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.1791 · Cited by 89
Steeghs, L., van Vliet, S. J., Uronen‐Hansson, H., et al. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00623.x · Cited by 86
Nitz, M., Ling, C., Otter, A., Cutler, J. E., & Bundle, D. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109274200 · Cited by 86
Mannose-mediated targeted immunoadjuvant action of liposomes.
Garçon, N., Gregoriadis, G., Taylor, M. E., & Summerfield, J. A. (1988) · PubMed · Cited by 83
Han, Y., & Cutler, J. E. (1997) · The Journal of Infectious Diseases · doi:10.1086/516455 · Cited by 83
Yeeprae, W., Kawakami, S., Yamashita, F., & Hashida, M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.010 · Cited by 82
Levels of complexity in pathogen recognition by C-type lectins
Cambi, A., & Figdor, C. G. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.05.011 · Cited by 80
Paoletti, L. C., Kasper, D. L., Michon, F., Fábio, J. L. D., Jennings, H. J., Tosteson, T. D., & Wessels, M. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115564 · Cited by 77
BARRATT, G. M., Tenu, J., Yapo, A., & Petit, J. F. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90479-7 · Cited by 76
Ellerbroek, P. M., Annemiek, B. S. P. E., Walenkamp, B. S. P., Hoepelman, B. S. P. A. I. M., & Coenjaerts, F. E. J. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043456188 · Cited by 76
Synthesis of Glycoconjugate Vaccines for Candida albicans Using Novel Linker Methodology
Wu, X., & Bundle, D. R. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo051065t · Cited by 75
Kole, L., Das, L., & Das, P. K. (1999) · The Journal of Infectious Diseases · doi:10.1086/314929 · Cited by 75
SHIMIZU, Y., TAKAGI, H., Nakayama, T., Yamakami, K., Tadakuma, T., Yokoyama, N., & KOJIMA, N. (2007) · Parasite Immunology · doi:10.1111/j.1365-3024.2007.00937.x · Cited by 74
An Extended Conformation of the Macrophage Mannose Receptor
Napper, C. E., Dyson, M. H., & Taylor, M. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100425200 · Cited by 72
Mannosylated Niosomes as Adjuvant-Carrier System for Oral Mucosal Immunization
Jain, S., & Vyas, S. P. (2006) · Journal of Liposome Research · doi:10.1080/08982100600992302 · Cited by 72
Oscarson, S., Alpe, M., Svahnberg, P., Nakouzi, A. S., & Casadevall, A. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.02.029 · Cited by 70
Kogelberg, H., Tolner, B., Sharma, S. K., Lowdell, M. W., Qureshi, U., Robson, M. P., Hillyer, T., Pedley, R. B., Vervecken, W., Contreras, R., et al. (2006) · Glycobiology · doi:10.1093/glycob/cwl053 · Cited by 69
Sarkar, S., & Das, N. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.12.010 · Cited by 68
Maitta, R. W., Datta, K., Lees, A., Belouski, S. S., & Pirofski, L. (2003) · Infection and Immunity · doi:10.1128/iai.72.1.196-208.2004 · Cited by 68
Liposome Mediated Affection of Monocytes
Huitinga, I., Damoiseaux, J. G. M. C., van Rooijen, N., Döpp, E. A., & Dijkstra, C. D. (1992) · Immunobiology · doi:10.1016/s0171-2985(11)80313-x · Cited by 66
Sprott, G. D., Dicaire, C. J., Gurnani, K., Sad, S., & Krishnan, L. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5235-5246.2004 · Cited by 65
Monsigny, M. L. P., Quétard, C., Bourgerie, S., Delay, D., Pichon, C., Midoux, P., Mayer, R., & Roche, A. (1998) · Biochimie · doi:10.1016/s0300-9084(98)80016-3 · Cited by 64
Ramakrishna, V., Vasilakos, J. P., Tario, J. D., Berger, M. A., Wallace, P. K., & Keler, T. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-5 · Cited by 63
Karanikas, V., Lodding, J., Maino, V. C., & McKenzie, I. F. C. (2000) · PubMed · Cited by 63
Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers
Opanasopit, P., Sakai, M., Nishikawa, M., Kawakami, S., Yamashita, F., & Hashida, M. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00006-8 · Cited by 61
Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration
Hattori, Y., Kawakami, S., Lu, Y. Q., Nakamura, K., Yamashita, F., & Hashida, M. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.910 · Cited by 60
Bioadhesive Mannosylated Nanoparticles for Oral Drug Delivery
Salman, H. H., Gamazo, C., Campanero, M. Á., et al. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.445 · Cited by 56
Self-citationNoguchi, Y., Noguchi, T., Sato, T., Yokoo, Y., Itoh, S., Yoshida, M., Yoshiki, T., Akiyoshi, K., Sunamoto, J., & Nakayama, E. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3599 · Cited by 49
Experimental Autoimmune Encephalomyelitis: CC Chemokine Receptor Expression by Trafficking Cells
Glabinski, A. R., Bielecki, B., O'Bryant, S., Selmaj, K. W., & Ransohoff, R. M. (2002) · Journal of Autoimmunity · doi:10.1006/jaut.2002.0613 · Cited by 47
Datta, N., Mukherjee, S., Das, L., & Das, P. K. (2003) · European Journal of Immunology · doi:10.1002/eji.200323671 · Cited by 46
Targeting of piperine intercalated in mannose-coated liposomes in experimental leishmaniasis.
Raay, B., Medda, S., Mukhopadhyay, S., & Basu, M. K. (1999) · PubMed · Cited by 44
DermaVir, a novel HIV immunisation technology
Lori, F., Trocio, J. N., Bakare, N., KELLY, L., & Lisziewicz, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.004 · Cited by 42
Binkert, C., Frigerio, M., Jones, A., Meyer, S., Pesenti, C., Prade, L., Viani, F., & Zanda, M. (2005) · ChemBioChem · doi:10.1002/cbic.200500180 · Cited by 40
Mannosylated liposomes for bio-film targeting
Vyas, S. P., Sihorkar, V., & Jain, S. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.034 · Cited by 39
Tan, M., Mommaas, A. M., Drijfhout, J. W., Jordens, R., Onderwater, J. J. M., Verwoerd, D., Mulder, A. A., van der Heiden, A. N., Ottenhoff, T. H. M., Cella, M., et al. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-9966-8_28 · Cited by 38
Higuchi, Y., Kawakami, S., Oka, M., Yabe, Y., Yamashita, F., & Hashida, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.05.059 · Cited by 37
Tanaka, M., Kaneda, Y., Fujii, S., Yamano, T., Hashimoto, K., Huang, S. K., & Hoon, D. S. �. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0537 · Cited by 37
Zysk, G., Brück, W., Huitinga, I., Fischer, F. R., Flachsbarth, F., van Rooijen, N., & Nau, R. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00173-7 · Cited by 37
Therapeutic vaccination for future management of HIV/AIDS
Lisziewicz, J. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00569-8 · Cited by 28
Oligolysine-based saccharide clusters: synthesis and specificity
Frison, N., Marceau, P., Roche, A., Monsigny, M. L. P., & Mayer, R. (2002) · Biochemical Journal · doi:10.1042/bj20020673 · Cited by 28
Biodistribution characteristics of mannosylated and fucosylated O/W emulsions in mice
Yeeprae, W., Kawakami, S., Higuchi, Y., Yamashita, F., & Hashida, M. (2005) · Journal of drug targeting · doi:10.1080/10611860500293367 · Cited by 28
Gijzen, K., Cambi, A., Torensma, R., & Figdor, C. G. (2006) · Current Protein and Peptide Science · doi:10.2174/138920306778018016 · Cited by 28
Immunogenicity of Liposomes Containing Lipid Core Peptides and the Adjuvant Quil A
White, K. L., Rades, T., Kearns, P. S., Tóth, I., & Hook, S. M. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0272-z · Cited by 27
Relevance of DC-SIGN in DC-induced T cell proliferation
Gijzen, K., Tacken, P. J., Zimmerman, A. W., Joosten, B., de Vries, I. J. M., Figdor, C. G., & Torensma, R. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0606414 · Cited by 23
Phospholipid Vesicle Targeting Using Synthetic Glycolipid and Other Determinantsa
Baldeschwieler, J. D. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb18413.x · Cited by 22
Chemoselective Ligation and Antigen Vectorization
Gras‐Masse, H. (2001) · Biologicals · doi:10.1006/biol.2001.0304 · Cited by 12
Micro-organism-like nanoparticles for oral antigen delivery
Salman, H. H., Gómez, S., Gamazo, C., Martins, R. C., Zabaleta, V., & Irache, J. M. (2008) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(08)50004-9 · Cited by 10
Self-citationAspects of cancer immunotherapy
McKenzie, I. F. C., Apostolopoulos, V., Plebanski, M., Pietersz, G. A., & Loveland, B. E. (2003) · Immunology and Cell Biology · doi:10.1046/j.0818-9641.2002.01140.x · Cited by 10
Narendran, P., Elsegood, K. A., Leech, N., Macindoe, W. M., Boons, G., & Dayan, C. M. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01825.x · Cited by 6
Cited by
Huh, A. J., & Kwon, Y. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.002 · Cited by 1,864
Targeting Strategies for Tissue-Specific Drug Delivery
Zhao, Z., Ukidve, A., Kim, J., & Mitragotri, S. (2020) · Cell · doi:10.1016/j.cell.2020.02.001 · Cited by 1,099
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
Ngambenjawong, C., Gustafson, H. H., & Pun, S. H. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.010 · Cited by 840
Lipids and Lipid Derivatives for RNA Delivery
Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00244 · Cited by 626
Folate-targeted therapeutic and imaging agents for cancer
Low, P. S., & Kularatne, S. A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.022 · Cited by 585
Metadata
- Authors
- Irache, J. M., Salman, H. H., Gamazo, C., & Espuelas, S.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2008-06
- Volume
- 5
- Issue
- 6
- Pages
- 703-724
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W1966009267
- Cited by
- 293
- References
- 143
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.